Apply on Employer Site

Karyopharm Therapeutics Inc. · 4 days ago

Karyopharm Talent Community

Newton, MA

Full-time

Onsite

New Grad, Entry Level

Karyopharm Therapeutics Inc. is inviting professionals to join their Talent Community, aimed at keeping individuals informed about career opportunities and company news. This initiative is designed for those interested in R&D, Commercial, Medical Affairs, or General & Administrative roles, providing a platform for connection and engagement with the company.

Health CareMedicalPharmaceutical

Comp. & Benefits

H1B Sponsor Likely

Qualification

Benefits

A culture of employee engagement, diversity, and inclusion

Peace of mind through best in class medical (deducible paid by KPTI), dental, vision, disability, and life insurance, parental leave, a matching 401k program (immediate vesting), ESPP and tuition reimbursement.

Wellness Program with a monthly stipend.

Generous Flex Time Off program and Holidays – we encourage you to recharge and spend time with family and friends.

Ample opportunities to learn and take on new responsibilities in a fast-paced, and patient focused company including management development & mentoring programs, and a variety of reward and recognition programs.

Company

Karyopharm Therapeutics Inc.

Founded in 2008

Newton, Massachusetts, USA

201-500 employees

http://www.karyopharm.com

H1B Sponsorship

Karyopharm Therapeutics Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)

Distribution of Different Job Fields Receiving Sponsorship

Represents job field similar to this job

Trends of Total Sponsorships

2025 (8)

2024 (2)

2023 (10)

2022 (8)

2021 (5)

2020 (10)

Funding

Current Stage

Public Company

Total Funding

$607.2M

Key Investors

Avidity PartnersForesite CapitalDelphi Ventures

2025-10-08Post Ipo Equity· $33M

2025-10-08Post Ipo Debt· $27.5M

2022-12-05Post Ipo Equity· $165M

Leadership Team

Brian Austad

Senior Vice President, Pharmaceutical Sciences

Sohanya Cheng

EVP, Chief Commercial Officer & Head of Business Development

Recent News

PR Newswire

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-01-03

Pharma Letter

Emerging therapies expected to reshape endometrial cancer market landscape

2025-11-08

TradingView

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

2025-11-04

Company data provided by crunchbase